Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
8.22
-0.64 (-7.22%)
Jul 24, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35.06 | Buy | Reiterates | $35.06 | +326.57% | Jul 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $23.84 | Buy | Initiates | $23.84 | +190.07% | Jun 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26.65 | Buy | Maintains | $26.65 | +224.19% | Jun 25, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.44 | Buy | Maintains | $22.44 | +173.00% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.43 | Buy | Reiterates | $15.43 | +87.69% | May 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $19.64 | Buy | Reiterates | $19.64 | +138.88% | May 5, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.64 | Buy | Maintains | $19.64 | +138.88% | Apr 28, 2026 |